New study tracks association between prenatal opioid exposure and health and education outcomes in children ages 0-18
This study followed nearly 900,000 children from birth to age 18 to understand how prenatal opioid exposure may be connected to long-term development. While Neonatal Abstinence Syndrome (NAS) and Neonatal Opioid Withdrawal Syndrome (NOWS) are often the focus in infancy, this research shows that the effects of prenatal opioid exposure can extend into childhood and adolescence. Importantly, these patterns were seen across a range of exposure levels—not just in children diagnosed with NAS/NOWS.
Study Link: Association between prenatal opioid exposure and health, education, and foster care between ages 0 and 18
Summary in Plain English:
Across health, education, and life experiences, children with prenatal opioid exposure were more likely to need additional support as they grew. Researchers found a consistent pattern: children with higher levels of exposure tended to have greater support needs, but even children with lower or less visible exposure showed meaningful differences compared to their peers. These differences were not limited to infancy—they continued through school age and into the teen years. At the same time, the study emphasizes that these are overall trends across large groups of children, and many factors—especially supportive caregiving and environment—play an important role in shaping each child’s path.
Here's what the researchers found:
Prenatal opioid exposure is more common than NAS/NOWS diagnoses suggest. Many children with exposure are not identified at birth.
Higher healthcare needs over time:
Children diagnosed with NAS had about 80% higher healthcare costs in early childhood.
Children with lower levels of exposure still had 70–80% higher healthcare use over time.
Increased need for school supports:
By adolescence, children with NAS were about 20 percentage points more likely to receive school-based support services.
Children with lower levels of exposure were about 10 percentage points more likely to need support.
Academic differences:
Children with prenatal opioid exposure scored 2–8% lower on early academic testing, with gaps widening over time.
They were 8–10 percentage points less likely to graduate high school on time.
Family and system-level impacts:
Families of children with NAS received hundreds of dollars more per month in support services on average.
Children with higher levels of exposure were much more likely to have early involvement with child protective services.
Patterns exist across all levels of exposure:
Even without a diagnosis of NAS/NOWS, children with prenatal opioid exposure showed meaningful differences in health, learning, and support needs.
Important context:
These findings show connections (associations), not direct cause-and-effect.
A child’s environment, relationships, and support systems continue to matter greatly.
What This Means For You:
If you are raising a child with prenatal opioid exposure, this research reflects something many caregivers already understand: your child may have evolving needs over time.
Even if your child did not have Neonatal Abstinence Syndrome (NAS) or Neonatal Opioid Withdrawal Syndrome (NOWS)—or if early symptoms resolved—differences may still appear later in areas like learning, regulation, or health.
The statistics in this study describe large groups of children. They do not predict your child’s individual future.
Many children benefit from supportive environments, predictable routines, and caregivers who understand how they experience the world.
You may find yourself advocating in school or healthcare settings. This is common and reflects your child’s needs—not your parenting.
Most importantly: children with prenatal opioid exposure have strengths, resilience, and the ability to thrive when supported appropriately.
Bottom line:
Your child’s journey may include extra support along the way—but with understanding, advocacy, and the right environment, they can continue to grow, learn, and succeed.
